Lumara Health Inc

Novobiotic Pharmaceuticals is a biotechnology company located in Cambridge, Massachusetts, specializing in the development of innovative pharmaceutical solutions. The company focuses on harnessing the potential of natural products, particularly from microbial sources, to address unmet medical needs. With a dedicated team of scientists and researchers, Novobiotic Pharmaceuticals is committed to advancing the field of drug discovery and development. Their work emphasizes the importance of scientific research in creating effective therapies for various health challenges. Generated from the website

DUSA Pharmaceuticals is a biopharmaceutical research and development company engaged in the development and marketing of its proprietary Levulan photodynamic and Levulan photodetection therapies for the treatment of multiple medical conditions. These products, when delivered to target tissues, are converted by fast growing cells into protoporphyrin IX, a potent photosensitizer, which can then be activated by an appropriate light source. The company s primary focus is in the area of dermatology. Both Levulan photodynamic and Levulan photodetection therapies utilize light-activated compounds to induce a therapeutic or detection effect. DUSA also markets Levulan Kerastick, a 20 percent topical solution that is part of a photodynamic therapy system to treat actinic keratoses, and BLU-U, a blue light photodynamic therapy illuminator that is intended for the treatment of nonhyperkeratotic actinic keratoses of the face or scalp. DUSA Pharmaceuticals maintains its corporate headquarters in Wilmington, Mass., and operates satellite offices in Valhalla, N.Y., and Toronto.

La Jolla Pharmaceutical Company is a biotechnology company engaged in the development of therapeutics for antibody-mediated autoimmune diseases afflicting several million people in the United States and Europe. The company is developing riquent for the treatment of patients with lupus kidney disease, a leading cause of sickness and death in lupus patients. The company is also developing small molecules to treat various other autoimmune and inflammatory conditions. The company's common stock is traded on the Nasdaq Stock Market under the symbol LJPC. La Jolla Pharmaceutical Company is headquartered in San Diego.